April 2012

Articles

EDITORIAL

BUSINESS ADVISOR

PAS IN PRACTICE

TECHNOLOGY CONNECTION

RESEARCH UPDATE

FEATURES

CLINICAL FOCUS: PEDIATRICS

SPECIAL REPORT

Therapeutics Update

View All News >
News
Atlantic Dermatological Conference on Meeting Calendar

The 89th strongAtlantic Dermatological Conference/strong hosted by the Dermatologic Society of Greater New York will be held April 27-29 at the Grand Hyatt Hotel, New York City. Register online at a href="http://www.DermSociety... more >

News
Brodalumab Moves Into Phase III for Moderate to Severe Psoriasis

Results from a Phase II study that evaluated the efficacy and safety of brodalumab in patients with moderate to severe psoriasis, show a higher mean percentage improvement in Psoriasis Area and Severity Index (PASI) score comp... more >

News
Early Data Presented for Ixekizumab In Chronic Plaque Psoriasis

Results for Eli Lilly and Company’s (NYSE: LLY) ixekizumab, an anti-IL-17 monoclonal antibody, show improved clinical symptoms in patients with moderate-to-severe plaque psoriasis. The randomized, double-blind, placebo-contro... more >

News
EHR iPad App Now Features Speech Recognition

The EZ DERM EHR iPad app is now powered by the cloudbased Nuance Healthcare 360 | Development Platform. The speech recognition platform provides CPU intensive speech and language processing in the cloud. The app will also permi... more >

Advertisement

TOP 5 ARTICLES FROM APRIL 2012